Publication details

Hypertenze a ischemická choroba srdeční – dva nebezpeční sourozenci

Title in English Hypertension and ischaemic heart disease - dangerous siblings
Authors

ŠPÁC Jiří

Year of publication 2017
Type Article in Periodical
Magazine / Source Kardiologická revue - Interní medicína
MU Faculty or unit

Faculty of Medicine

Citation
Field Other specializations of internal medicine
Keywords ischaemic heart disease; hypertension; angina pectoris; acute coronary syndromes; treatment of hypertension
Description Epidemiological studies suggest a strong association between hypertension and ischaemic heart disease (IHD), and hypertension is a major independent risk factor for the development of cardiovascular disease (CVD), including myocardial infarction (MI). Increased blood pressure (BP) also enhances coronary arteriosclerosis, and the combination of myocardial and coronary effects increases the risk of myocardial infarction and arrhythmias. The primary objective of the management of hypertension in patients with IHD is modification of the balance between myocardial oxygen supply and demand to improve the symptoms and reduce future cardiovascular adverse events. This review discusses which antihypertensive drugs should be used in patients who have been diagnosed with IHD with angina pectoris, in those with acute coronary syndromes and MI. Appropriate management should include beta-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and calcium channel blockers. In post-acute coronary syndrome (ACS) patients, a J- or U-shaped curve association existed between BP and the risk of future cardiovascular events, which suggests that too low a pressure may be dangerous in patients with a severe form of coronary atherosclerosis.

You are running an old browser version. We recommend updating your browser to its latest version.

More info